Apostolos Stathopoulos
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Enhancing brain entry and therapeutic activity of chimeric antigen receptor T cells with intra-arterial NEO100 in a mouse model of CNS lymphoma.
Journal: Journal of neurosurgery
Published: June 26, 2023
Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignancies.
Journal: Journal of neurosurgery
Published: June 16, 2022
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.
Journal: Frontiers in oncology
Published: May 02, 2022
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts.
Journal: CNS oncology
Published: August 31, 2018
Therapeutic Immunization against Glioblastoma.
Journal: International journal of molecular sciences
Published: July 14, 2018
Use of ERC-1671 Vaccine in a Patient with Recurrent Glioblastoma Multiforme after Progression during Bevacizumab Therapy: First Published Report.
Journal: The Permanente journal
Published: March 19, 2015
Immune adjuvants as critical guides directing immunity triggered by therapeutic cancer vaccines.
Journal: Cytotherapy
Published: June 12, 2013
Burns during Easter festivities in Greece.
Journal: Annals of burns and fire disasters
Published: October 18, 2012
Therapeutic targeting of malignant glioma.
Journal: Anti-cancer agents in medicinal chemistry
Published: October 01, 2012
Last Updated: 09/26/2026